Trillium Therapeutics Inc. (NASDAQ/TSX:TRIL) is an immuno-oncology company dedicated to the discovery and development of novel and innovative cancer therapies.

EMAIL ALERTS

Email Address: *
First Name:
Mailing Lists

 
Enter the code shown above.

Powered By Q4 Inc. 5.12.0.5